Jun 26, 2013, 03.40 PM | Source: Moneycontrol.com
The report states that Sanofi and GSK have put in non-binding bids and Novartis has signed a non-disclosure agreement to acquire the domestic formulations business of Elder Pharma.
Shares of Mumbai-based Elder Pharmaceuticals jumped 5 percent to hit the upper circuit limit of Rs 309.50 on NSE on Wednesday after a report in the Economic Times paper said global pharma majors like Sanofi Aventis , Novartis and GlaxoSmithKline were in the race to buy-out the debt ridden company's domestic formulations business.
While Sanofi and GSK have put in non-binding bids, Novartis has signed a non-disclosure agreement, the report said, adding that even a few private equity players planned to join the bidding process.
Earlier this month, the paper had reported that the whole company was up for sale and Elder had mandated Ernst & Young and Japanese investment bank Nomura to manage a formal process to find a buyer.
Alok Saxena, the company's MD had termed that earlier report as a "market rumour."
Elder Pharma has a debt of around Rs 1,300 crore. In FY13, the company reported a net profit of Rs 81 crore on revenue of Rs 1,457 crore. It paid Rs 107 crore in finance costs.
Elder Pharmaceuticals' board meeting on February 03, 2016
Elder Pharmaceuticals Ltd has informed BSE that a
Elder Pharma appoints Ravani Mohammed Abdul as additional directors
Elder Pharmaceuticals has informed that the Promot
Sun Pharma Q3 profit seen up 4.4%, Gleevec & Halol key
Operating profit (earnings before interest, tax, d
Natco Pharma Q3 net profit rises over two-fold to Rs 37.15 cr
The company had posted a net profit of Rs 14.34 cr
Aurobindo Pharma gets USFDA nod for Levofloxacin injection
The approval is for Levofloxacin in 5 percent Dext
Natco Pharma: Outcome of board meeting
Natco Pharma Ltd has informed BSE that the Board o
Aurobindo Pharma receives USFDA approval for Levofloxacin in Dextrose Injection
Aurobindo Pharma has received final approval from
Buy pharma stocks, says Dhananjay Sinha
Dhananjay Sinha of Emkay Global Fin Services is of